▶ 調査レポート

免疫性血小板減少薬の世界市場 2019年版:種類別(トロンボポエチン受容体作動薬(TPO-RA)、コルチコステロイド、静脈内免疫グロブリン(IVIG)、その他の薬物)、用途別(バイオテクノロジーおよび製薬会社、病院および診断センター、学術機関および研究機関)

• 英文タイトル:Global Immune Thrombocytopenia Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。免疫性血小板減少薬の世界市場 2019年版:種類別(トロンボポエチン受容体作動薬(TPO-RA)、コルチコステロイド、静脈内免疫グロブリン(IVIG)、その他の薬物)、用途別(バイオテクノロジーおよび製薬会社、病院および診断センター、学術機関および研究機関) / Global Immune Thrombocytopenia Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / C-GIR20G2772資料のイメージです。• レポートコード:C-GIR20G2772
• 出版社/出版日:GlobalInfoResearch / 2019年12月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「免疫性血小板減少薬の世界市場2019年」は、グローバルにおける免疫性血小板減少薬市場を展望するレポートです。免疫性血小板減少薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどを掲載しています。
・免疫性血小板減少薬の市場概観
・免疫性血小板減少薬の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・免疫性血小板減少薬の企業別販売動向、市場シェア、市場集中度、競争動向
・免疫性血小板減少薬の世界市場規模
・免疫性血小板減少薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・免疫性血小板減少薬のアメリカ市場規模推移
・免疫性血小板減少薬のカナダ市場規模推移
・免疫性血小板減少薬のメキシコ市場規模推移
・免疫性血小板減少薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・免疫性血小板減少薬のドイツ市場規模推移
・免疫性血小板減少薬のイギリス市場規模推移
・免疫性血小板減少薬のロシア市場規模推移
・免疫性血小板減少薬のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・免疫性血小板減少薬の日本市場規模推移
・免疫性血小板減少薬の中国市場規模推移
・免疫性血小板減少薬の韓国市場規模推移
・免疫性血小板減少薬のインド市場規模推移
・免疫性血小板減少薬の東南アジア市場規模推移
・免疫性血小板減少薬の南米市場分析(ブラジル、アルゼンチン等)
・免疫性血小板減少薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・免疫性血小板減少薬の種類別分析/販売量、売上、市場シェア(トロンボポエチン受容体作動薬(TPO-RA)、コルチコステロイド、静脈内免疫グロブリン(IVIG)、その他の薬物)
・免疫性血小板減少薬の用途別分析/市場規模(バイオテクノロジーおよび製薬会社、病院および診断センター、学術機関および研究機関)
・免疫性血小板減少薬の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・免疫性血小板減少薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Immune Thrombocytopenia Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immune Thrombocytopenia Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Immune Thrombocytopenia Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immune Thrombocytopenia Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Amgen Inc.
Merck & Co., Inc.
CSL Ltd.
Horizon Therapeutics Plc
Rigel Pharmaceuticals Inc.
Novartis AG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Thrombopoietin Receptor Agonists (TPO-RAs)
Corticosteroids
Intravenous Immunoglobins (IVIGs)
Other Drugs

Market Segment by Applications, can be divided into
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Centers
Academic Institutes and Research Organizations

レポート目次

Table of Contents

1 Immune Thrombocytopenia Drugs Market Overview
1.1 Product Overview and Scope of Immune Thrombocytopenia Drugs
1.2 Classification of Immune Thrombocytopenia Drugs by Types
1.2.1 Global Immune Thrombocytopenia Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Immune Thrombocytopenia Drugs Revenue Market Share by Types in 2018
1.2.3 Thrombopoietin Receptor Agonists (TPO-RAs)
1.2.4 Corticosteroids
1.2.5 Intravenous Immunoglobins (IVIGs)
1.2.6 Other Drugs
1.3 Global Immune Thrombocytopenia Drugs Market by Application
1.3.1 Global Immune Thrombocytopenia Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Hospitals and Diagnostic Centers
1.3.4 Academic Institutes and Research Organizations
1.4 Global Immune Thrombocytopenia Drugs Market by Regions
1.4.1 Global Immune Thrombocytopenia Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Immune Thrombocytopenia Drugs (2014-2024)
2 Company Profiles
2.1 Amgen Inc.
2.1.1 Business Overview
2.1.2 Immune Thrombocytopenia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck & Co., Inc.
2.2.1 Business Overview
2.2.2 Immune Thrombocytopenia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL Ltd.
2.3.1 Business Overview
2.3.2 Immune Thrombocytopenia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Ltd. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Horizon Therapeutics Plc
2.4.1 Business Overview
2.4.2 Immune Thrombocytopenia Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Rigel Pharmaceuticals Inc.
2.5.1 Business Overview
2.5.2 Immune Thrombocytopenia Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis AG
2.6.1 Business Overview
2.6.2 Immune Thrombocytopenia Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis AG Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Immune Thrombocytopenia Drugs Market Competition, by Players
3.1 Global Immune Thrombocytopenia Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Immune Thrombocytopenia Drugs Players Market Share
3.2.2 Top 10 Immune Thrombocytopenia Drugs Players Market Share
3.3 Market Competition Trend
4 Global Immune Thrombocytopenia Drugs Market Size by Regions
4.1 Global Immune Thrombocytopenia Drugs Revenue and Market Share by Regions
4.2 North America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
5 North America Immune Thrombocytopenia Drugs Revenue by Countries
5.1 North America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
5.2 USA Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6 Europe Immune Thrombocytopenia Drugs Revenue by Countries
6.1 Europe Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
6.2 Germany Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.4 France Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Immune Thrombocytopenia Drugs Revenue by Countries
7.1 Asia-Pacific Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
7.2 China Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.5 India Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
8 South America Immune Thrombocytopenia Drugs Revenue by Countries
8.1 South America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
8.2 Brazil Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Immune Thrombocytopenia Drugs by Countries
9.1 Middle East and Africa Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
10 Global Immune Thrombocytopenia Drugs Market Segment by Type
10.1 Global Immune Thrombocytopenia Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Immune Thrombocytopenia Drugs Market Forecast by Type (2019-2024)
10.3 Thrombopoietin Receptor Agonists (TPO-RAs) Revenue Growth Rate (2014-2024)
10.4 Corticosteroids Revenue Growth Rate (2014-2024)
10.5 Intravenous Immunoglobins (IVIGs) Revenue Growth Rate (2014-2024)
10.6 Other Drugs Revenue Growth Rate (2014-2024)
11 Global Immune Thrombocytopenia Drugs Market Segment by Application
11.1 Global Immune Thrombocytopenia Drugs Revenue Market Share by Application (2014-2019)
11.2 Immune Thrombocytopenia Drugs Market Forecast by Application (2019-2024)
11.3 Biotechnology and Pharmaceutical Companies Revenue Growth (2014-2019)
11.4 Hospitals and Diagnostic Centers Revenue Growth (2014-2019)
11.5 Academic Institutes and Research Organizations Revenue Growth (2014-2019)
12 Global Immune Thrombocytopenia Drugs Market Size Forecast (2019-2024)
12.1 Global Immune Thrombocytopenia Drugs Market Size Forecast (2019-2024)
12.2 Global Immune Thrombocytopenia Drugs Market Forecast by Regions (2019-2024)
12.3 North America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.6 South America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Immune Thrombocytopenia Drugs Picture
Table Product Specifications of Immune Thrombocytopenia Drugs
Table Global Immune Thrombocytopenia Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Types in 2018
Figure Thrombopoietin Receptor Agonists (TPO-RAs) Picture
Figure Corticosteroids Picture
Figure Intravenous Immunoglobins (IVIGs) Picture
Figure Other Drugs Picture
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Application (2014-2024)
Figure Immune Thrombocytopenia Drugs Revenue Market Share by Applications in 2018
Figure Biotechnology and Pharmaceutical Companies Picture
Figure Hospitals and Diagnostic Centers Picture
Figure Academic Institutes and Research Organizations Picture
Table Global Market Immune Thrombocytopenia Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen Inc. Immune Thrombocytopenia Drugs Type and Applications
Table Amgen Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Immune Thrombocytopenia Drugs Type and Applications
Table Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Ltd. Basic Information, Manufacturing Base and Competitors
Table CSL Ltd. Immune Thrombocytopenia Drugs Type and Applications
Table CSL Ltd. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Horizon Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Type and Applications
Table Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Rigel Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Type and Applications
Table Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Immune Thrombocytopenia Drugs Type and Applications
Table Novartis AG Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Share by Players (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Players in 2017
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Immune Thrombocytopenia Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Immune Thrombocytopenia Drugs Revenue Market Share in 2018
Figure Global Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Regions in 2018
Figure North America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure South America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table North America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
Table North America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure USA Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Europe Immune Thrombocytopenia Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure Germany Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure UK Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure France Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Immune Thrombocytopenia Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure China Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure India Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table South America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
Table South America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure Brazil Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Immune Thrombocytopenia Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Share by Type (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Type (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Type in 2018
Table Global Immune Thrombocytopenia Drugs Revenue Forecast by Type (2019-2024)
Figure Global Immune Thrombocytopenia Drugs Market Share Forecast by Type (2019-2024)
Figure Global Thrombopoietin Receptor Agonists (TPO-RAs) Revenue Growth Rate (2014-2019)
Figure Global Corticosteroids Revenue Growth Rate (2014-2019)
Figure Global Intravenous Immunoglobins (IVIGs) Revenue Growth Rate (2014-2019)
Figure Global Other Drugs Revenue Growth Rate (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue by Application (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Application in 2018
Table Global Immune Thrombocytopenia Drugs Revenue Forecast by Application (2019-2024)
Figure Global Immune Thrombocytopenia Drugs Market Share Forecast by Application (2019-2024)
Figure Global Biotechnology and Pharmaceutical Companies Revenue Growth Rate (2014-2019)
Figure Global Hospitals and Diagnostic Centers Revenue Growth Rate (2014-2019)
Figure Global Academic Institutes and Research Organizations Revenue Growth Rate (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure Europe Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure South America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)